Antineoplastic Combined Chemotherapy Protocols Concept

subject area of

• A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.  Academic Article
• A Phase I study of the combination of oxaliplatin/docetaxel and vandetanib for the treatment of advanced gastroesophageal cancer.  Academic Article
• A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium.  Academic Article
• A comparison of elderly patients with aggressive histology lymphoma who were entered or not entered on to a randomized phase II trial.  Academic Article
• A dose escalation trial of adjuvant cyclophosphamide and epirubicin in combination with 5-fluorouracil using G-CSF support for premenopausal women with breast cancer involving four or more positive nodes.  Academic Article
• A fatal case of Pneumocystis jirovecii pneumonia in a breast cancer patient receiving weekly paclitaxel and trastuzumab.  Academic Article
• A four gene signature of chromosome instability (CIN4) predicts for benefit from taxanes in the NCIC-CTG MA21 clinical trial.  Academic Article
• A four gene signature predicts benefit from anthracyclines: evidence from the BR9601 and MA.5 clinical trials.  Academic Article
• A multicenter, randomized, open-label study to assess the steady-state pharmacokinetics of bevacizumab given with either XELOX or FOLFOX-4 in patients with metastatic colorectal cancer.  Academic Article
• A pharmacogenetic analysis of the Canadian Cancer Trials Group MY.10 clinical trial of maintenance therapy for multiple myeloma.  Academic Article
• A phase I study of OGX-011, a 2'-methoxyethyl phosphorothioate antisense to clusterin, in combination with docetaxel in patients with advanced cancer.  Academic Article
• A phase I study of OSI-211 and cisplatin as intravenous infusions given on days 1, 2 and 3 every 3 weeks in patients with solid cancers.  Academic Article
• A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies.  Academic Article
• A phase I study of pegylated liposomal doxorubicin hydrochloride (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small-cell lung cancer.  Academic Article
• A phase I study of the combination of ro4929097 and cediranib in patients with advanced solid tumours (PJC-004/NCI 8503).  Academic Article
• A phase I study of the oral gamma secretase inhibitor R04929097 in combination with gemcitabine in patients with advanced solid tumors (PHL-078/CTEP 8575).  Academic Article
• A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over.  Academic Article
• A phase I trial of ANG1/2-Tie2 inhibitor trebaninib (AMG386) and temsirolimus in advanced solid tumors (PJC008/NCI♯9041).  Academic Article
• A phase I trial of high-dose paclitaxel, cyclophosphamide and mitoxantrone with autologous blood stem cell support for the treatment of metastatic breast cancer.  Academic Article
• A phase I trial of standard and cyclophosphamide dose-escalated CHOP with granulocyte colony stimulating factor in elderly patients with non-Hodgkin's lymphoma.  Academic Article
• A phase I trial of tipifarnib with radiation therapy, with and without temozolomide, for patients with newly diagnosed glioblastoma.  Academic Article
• A phase I, dose-escalation trial of continuous- and pulsed-dose afatinib combined with pemetrexed in patients with advanced solid tumors.  Academic Article
• A phase I-II study of oblimersen sodium (G3139, Genasense) in combination with doxorubicin in advanced hepatocellular carcinoma (NCI # 5798).  Academic Article
• A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortium.  Academic Article
• A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186.  Academic Article
• A phase II study of doxorubicin/paclitaxel plus G-CSF for metastatic breast cancer.  Academic Article
• A phase II study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in relapsed small cell lung cancer.  Academic Article
• A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer.  Academic Article
• A phase II trial of dovitinib in previously-treated advanced pleural mesothelioma: The Ontario Clinical Oncology Group.  Academic Article
• A pilot study of carboplatin augmentation therapy for patients with poor risk acute non-lymphocytic leukemia.  Academic Article
• A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer.  Academic Article
• A pilot study to investigate the feasibility and cardiac effects of pegylated liposomal doxorubicin (PL-DOX) as adjuvant therapy in medically fit elderly breast cancer patients.  Academic Article
• A prognostic factor index for overall survival in patients receiving first-line chemotherapy for HER2-negative advanced breast cancer: an analysis of the ATHENA trial.  Academic Article
• A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma.  Academic Article
• A randomised comparison of melphalan with prednisone or dexamethasone as induction therapy and dexamethasone or observation as maintenance therapy in multiple myeloma: NCIC CTG MY.7.  Academic Article
• A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy naïve castration-resistant prostate cancer.  Academic Article
• A randomized phase II study of cediranib alone versus cediranib in combination with dasatinib in docetaxel resistant, castration resistant prostate cancer patients.  Academic Article
• A randomized trial comparing 12 weeks versus 36 weeks of adjuvant chemotherapy in stage II breast cancer.  Academic Article
• A randomized trial of maintenance versus no maintenance melphalan and prednisone in responding multiple myeloma patients.  Academic Article
• A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma.  Academic Article
• A systematic review of optimal treatment strategies for localized Ewing's sarcoma of bone after neo-adjuvant chemotherapy.  Academic Article
• ABVD alone versus radiation-based therapy in limited-stage Hodgkin's lymphoma.  Academic Article
• Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?  Academic Article
• Abiraterone in metastatic prostate cancer without previous chemotherapy.  Academic Article
• Acute lymphoid leukemia. No evidence of consistent chemotherapy-induced intestinal malabsorption.  Academic Article
• Acute perforative appendicitis during preoperative chemotherapy for Wilms tumor.  Academic Article
• Addition of verapamil and tamoxifen to the initial chemotherapy of small cell lung cancer. A phase I/II study.  Academic Article
• Addressing taxane resistance in metastatic castration-resistant prostate cancer: a focus on chaperone proteins.  Academic Article
• Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer.  Academic Article
• Adjuvant Chemotherapy Is Associated With Improved Overall Survival in Locally Advanced Rectal Cancer After Achievement of a Pathologic Complete Response to Chemoradiation.  Academic Article
• Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial.  Academic Article
• Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial.  Academic Article
• Adjuvant chemotherapy for breast cancer--30 years later.  Academic Article
• Adjuvant sunitinib following chemoradiotherapy and surgery for locally advanced esophageal cancer: a phase II trial.  Academic Article
• Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care's gastrointestinal cancer disease site group.  Academic Article
• Adriamycin and cisplatin in the treatment of stage III and IV epithelial ovarian carcinoma.  Academic Article
• Advanced ovarian cancer: phase III randomized study of sequential cisplatin-topotecan and carboplatin-paclitaxel vs carboplatin-paclitaxel.  Academic Article
• Alemtuzumab and CHOP Chemotherapy for the Treatment of Aggressive Histology Peripheral T Cell Lymphomas: A Multi-Center Phase I Study.  Academic Article
• Altered mineral metabolism and bone mass in children during treatment for acute lymphoblastic leukemia.  Academic Article
• An atypical case of bilateral posterior scleritis in a patient with chronic lymphocytic leukemia.  Academic Article
• An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphoma.  Academic Article
• Analysis of dose intensity for adjuvant chemotherapy trials in stage II breast cancer.  Academic Article
• Analysis of dose intensity for chemotherapy in early (stage II) and advanced breast cancer.  Academic Article
• Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience.  Academic Article
• Anticoagulation and bleeding: a pooled analysis of lung cancer trials of the NCIC Clinical Trials Group.  Academic Article
• Assessment of Referral and Chemotherapy Treatment Patterns for Elderly Patients With Non-small-Cell Lung Cancer.  Academic Article
• Autologous stem cell transplantation in follicular lymphoma: a systematic review and meta-analysis.  Academic Article
• Balancing risks and benefits of therapy for patients with favorable-risk limited-stage Hodgkin lymphoma: the role of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy alone.  Academic Article
• Better treatments that cost more: the dilemma.  Academic Article
• Bleomycin-induced lung toxicity and pentoxifylline.  Academic Article
• Bortezomib ADDED to R-CVP is safe and effective for previously untreated advanced-stage follicular lymphoma: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Cancer Care Ontario and American Society of Clinical Oncology adjuvant chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable non small-cell lung cancer guideline.  Academic Article
• Carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in partially platinum-sensitive ovarian cancer patients: results from a subset analysis of the CALYPSO phase III trial.  Academic Article
• Cardiac safety of adjuvant pegylated liposomal doxorubicin with concurrent trastuzumab: a randomized phase II trial.  Academic Article
• Cervical cancer during pregnancy.  Academic Article
• Chemoradiotherapy with or without panitumumab in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-1): a randomised, controlled, open-label phase 2 trial.  Academic Article
• Chemotherapy and endocrine therapy in metastatic disease.  Academic Article
• Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial.  Academic Article
• Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?  Academic Article
• Chemotherapy for colorectal cancer.  Academic Article
• Chemotherapy for older patients with newly diagnosed, advanced-stage, aggressive-histology non-Hodgkin lymphoma: a systematic review.  Academic Article
• Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer.  Academic Article
• Chemotherapy with gemcitabine-containing regimens for locally recurrent or metastatic nasopharyngeal carcinoma.  Academic Article
• Chemotherapy-induced infiltrative pneumonitis cases in breast cancer patients.  Academic Article
• Childhood atypical teratoid rhabdoid tumor of the central nervous system: a meta-analysis of observational studies.  Academic Article
• Clinical cooperative trials of the National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  Academic Article
• Clinical evidence of a cumulative effect of high-dose cytarabine on the cerebellum in patients with acute leukemia: a leukemia intergroup report.  Academic Article
• Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer.  Academic Article
• Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer.  Academic Article
• Clinical trial update: National Cancer Institute of Canada.  Academic Article
• Cognitive Function in Patients With Colorectal Cancer Who Do and Do Not Receive Chemotherapy: A Prospective, Longitudinal, Controlled Study.  Academic Article
• Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers.  Academic Article
• Colorectal cancer in young adults.  Academic Article
• Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors.  Academic Article
• Combination epigenetic therapy has efficacy in patients with refractory advanced non-small cell lung cancer.  Academic Article
• Combined Stimulation with Interleukin-18 and Interleukin-12 Potently Induces Interleukin-8 Production by Natural Killer Cells.  Academic Article
• Combined methotrexate-dactinomycin: an effective therapy for low-risk gestational trophoblastic neoplasia.  Academic Article
• Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.  Academic Article
• Combined treatment of a murine breast cancer model with type 5 adenovirus vectors expressing murine angiostatin and IL-12: a role for combined anti-angiogenesis and immunotherapy.  Academic Article
• Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial.  Conference Paper
• Commentary: anthracyclines in early-stage breast cancer: is it the end of an era?  Academic Article
• Comparison of infectious complications during induction/consolidation chemotherapy versus allogeneic hematopoietic stem cell transplantation.  Academic Article
• Comparison of outcomes of phase II studies and subsequent randomized control studies using identical chemotherapeutic regimens.  Conference Paper
• Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein thrombosis in the upper body in children: results of the PARKAA study. Prophylactic Antithrombin Replacement in Kids with ALL treated with Asparaginase.  Academic Article
• Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.  Academic Article
• Complementary and alternative medicine use among women receiving chemotherapy for ovarian cancer in 2 patient populations.  Academic Article
• Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer--a meta-analysis.  Academic Article
• Concurrent cisplatin-based chemotherapy plus radiotherapy for cervical cancer: a meta-analysis.  Academic Article
• Consolidation therapy with autologous bone marrow transplantation in adults with acute myeloid leukemia: a meta-analysis.  Academic Article
• Conventional and complementary therapies: a tale of two research standards?  Academic Article
• Cost-effectiveness of a transplantation strategy compared to melphalan and prednisone in younger patients with multiple myeloma.  Academic Article
• Current status and future innovations of hormonal agents, chemotherapy and investigational agents in endometrial cancer.  Academic Article
• Custirsen (OGX-011) combined with cabazitaxel and prednisone versus cabazitaxel and prednisone alone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel (AFFINITY): a randomised, open-label, international, phase 3 trial.  Academic Article
• Custirsen in combination with docetaxel and prednisone for patients with metastatic castration-resistant prostate cancer (SYNERGY trial): a phase 3, multicentre, open-label, randomised trial.  Academic Article
• Cyclophosphamide and fluorouracil combined with mitoxantrone versus doxorubicin for breast cancer: superiority of doxorubicin.  Academic Article
• Cyclophosphamide, epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer.  Academic Article
• Cytoreduction and hyperthermic intraperitoneal chemotherapy (CS/HIPEC) in colorectal cancer: Evidence-based review of patient selection and treatment algorithms.  Academic Article
• Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: a phase II randomized study.  Academic Article
• Decision framework for chemotherapeutic interventions for metastatic non-small-cell lung cancer.  Academic Article
• Disabling encephalopathy during 5-fluorouracil and levamisole adjuvant therapy for resected colorectal cancer: a report of two cases.  Academic Article
• Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: updated survival in the TAX 327 study.  Academic Article
• Dose intensity and lymphoma.  Academic Article
• Double heterozygosity for germline mutations in BRCA1 and p53 in a woman with early onset breast cancer.  Academic Article
• Drug-induced stomatocytosis and anemia during consolidation chemotherapy of childhood acute leukemia.  Academic Article
• Dual-agent molecular targeting of the ErbB2 receptor: killing one bird with two stones.  Academic Article
• Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.  Academic Article
• Dyspermia in men with localized Hodgkin's disease. A potentially reversible, immune-mediated disorder.  Academic Article
• Early Occurrence of Angiosarcoma in a Woman With a BRCA2 Gene Variation of Unknown Significance Treated With Breast-Conserving Therapy for Bilateral Ductal Carcinoma: A Case Report.  Academic Article
• Early and late changes in markers of aortic stiffness with breast cancer therapy.  Academic Article
• Early prediction of therapy responses and outcomes in breast cancer patients using quantitative ultrasound spectral texture.  Academic Article
• Economic Evaluation of Bevacizumab for the First-Line Treatment of Newly Diagnosed Glioblastoma Multiforme.  Academic Article
• Effect of disease and chemotherapy on hemostasis in children with acute lymphoid leukemia.  Academic Article
• Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12^.  Academic Article
• Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 study.  Academic Article
• Effect of zoledronic acid on the doxycycline-induced decrease in tumour burden in a bone metastasis model of human breast cancer.  Academic Article
• Efficacy of docetaxel-based chemotherapy following ketoconazole in metastatic castration-resistant prostate cancer: implications for prior therapy in clinical trials.  Academic Article
• Eight Cycles of ABVD Versus Four Cycles of BEACOPPescalated Plus Four Cycles of BEACOPPbaseline in Stage III to IV, International Prognostic Score ≥ 3, High-Risk Hodgkin Lymphoma: First Results of the Phase III EORTC 20012 Intergroup Trial.  Academic Article
• Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.  Academic Article
• Endocrine disorders following treatment of childhood brain tumours.  Academic Article
• Enhancing Endocrine Therapy Combination Strategies for the Treatment of Postmenopausal HR+/HER2- Advanced Breast Cancer.  Academic Article
• Epidermal growth factor receptor: pathway, therapies, and pipeline.  Academic Article
• Escalated as compared with standard doses of doxorubicin in BACOP therapy for patients with non-Hodgkin's lymphoma.  Academic Article
• Evaluating the value of number of cycles of docetaxel and prednisone in men with metastatic castration-resistant prostate cancer.  Academic Article
• Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination.  Academic Article
• Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.  Conference Paper
• Evidence-based focused review of the role of radiation therapy in the treatment of early-stage Hodgkin lymphoma.  Academic Article
• Evidence-based guideline recommendations on treatment strategies for localized Ewing's sarcoma of bone following neo-adjuvant chemotherapy.  Academic Article
• Examining the safety and efficacy of a chemotherapy dosing method in Allogeneic Stem Cell Transplant patients of extreme body size.  Academic Article
• Expression of p27 in residual rectal cancer after preoperative chemoradiation predicts long-term outcome.  Academic Article
• Fatigue in people with localized colorectal cancer who do and do not receive chemotherapy: a longitudinal prospective study.  Academic Article
• Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.  Academic Article
• Feasibility and efficacy of repeated chemotherapy for progressive pediatric low-grade gliomas.  Academic Article
• Final overall survival results and effect of prolonged (≥ 1 year) first-line bevacizumab-containing therapy for metastatic breast cancer in the ATHENA trial.  Academic Article
• First-line bevacizumab plus taxane-based chemotherapy for locally recurrent or metastatic breast cancer: safety and efficacy in an open-label study in 2,251 patients.  Academic Article
• First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review.  Academic Article
• Foreign body reaction mimicking breast carcinoma in patient with stage IV ovarian cancer.  Academic Article
• Future directions for research on Silybum marianum for cancer patients.  Academic Article
• GATA-3 expression is not associated with complete pathological response in triple negative breast cancer patients treated with neoadjuvant chemotherapy.  Academic Article
• Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study.  Academic Article
• Gemcitabine and vinorelbine in recurrent advanced non-small cell lung cancer: sequence does matter.  Academic Article
• Gemcitabine concurrent with continuous infusional 5-fluorouracil in advanced biliary cancers: a review of the Princess Margaret Hospital experience.  Academic Article
• Gemcitabine, dexamethasone and cisplatin is an active and non-toxic chemotherapy regimen in relapsed or refractory Hodgkin's disease: a phase II study by the National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Gemcitabine, dexamethasone, and cisplatin in patients with recurrent or refractory aggressive histology B-cell non-Hodgkin lymphoma: a Phase II study by the National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG).  Academic Article
• Gemcitabine/dexamethasone/cisplatin vs cytarabine/dexamethasone/cisplatin for relapsed or refractory aggressive-histology lymphoma: cost-utility analysis of NCIC CTG LY.12.  Academic Article
• Global, multicenter, randomized, phase II trial of gemcitabine and gemcitabine plus AGS-1C4D4 in patients with previously untreated, metastatic pancreatic cancer.  Academic Article
• Guideline for the classification of the acute emetogenic potential of antineoplastic medication in pediatric cancer patients.  Academic Article
• HER2 and responsiveness of breast cancer to adjuvant chemotherapy.  Academic Article
• Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.  Academic Article
• Hematopoietic colony-stimulating factor priming does not influence survival in acute myeloid leukemia: a meta-analysis of randomized trials.  Academic Article
• Hemophagocytic lymphohistiocytosis onset during induction therapy for precursor B-cell acute lymphoblastic leukemia.  Academic Article
• High dose therapy with stem cell support for breast cancer: the jury is still out.  Academic Article
• Hospital and home chemotherapy for children with leukemia: a randomized cross-over study.  Academic Article
• Hypomagnesemia associated with chemotherapy in patients treated for acute lymphoblastic leukemia: possible mechanisms.  Academic Article
• Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): a randomised, double-blind, phase 3 study.  Academic Article
• Immediate versus delayed access of implantable venous access devices: does the timing of access make a difference to the frequency of complications?  Academic Article
• Impact of chemotherapy on thrombin generation and on the protein C pathway in breast cancer patients.  Academic Article
• Impact of registration on clinical trials on infection risk in pediatric acute myeloid leukemia.  Academic Article
• Impact of the addition of chemotherapy to radiotherapy for oropharyngeal cancer in 2003-2004: Population-based study from the Province of Ontario, Canada.  Academic Article
• Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01.  Academic Article
• Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer.  Academic Article
• Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5.  Academic Article
• Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer.  Academic Article
• Increased thromboembolic complications with concurrent tamoxifen and chemotherapy in a randomized trial of adjuvant therapy for women with breast cancer. National Cancer Institute of Canada Clinical Trials Group Breast Cancer Site Group.  Academic Article
• Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet.  Academic Article
• Induction failure in acute lymphoblastic leukemia of childhood.  Academic Article
• Inhibition of the colony-stimulating-factor-1 receptor affects the resistance of lung cancer cells to cisplatin.  Academic Article
• Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.  Academic Article
• Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.  Academic Article
• Interleukin-1 beta expression and treatment outcome in acute myelogenous leukemia.  Academic Article
• Is there convincing evidence for the use of chemotherapy alone in patients with limited stage Hodgkin's lymphoma?  Academic Article
• Lack of correlation of P-glycoprotein expression with response to MIC chemotherapy in oesophageal cancer.  Academic Article
• Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.  Academic Article
• Lapatinib or Trastuzumab Plus Taxane Therapy for Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: Final Results of NCIC CTG MA.31.  Academic Article
• Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.  Academic Article
• Lenalidomide plus melphalan without prednisone for previously untreated older patients with multiple myeloma: a phase II trial.  Academic Article
• Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis.  Academic Article
• Limited-stage hodgkin lymphoma: managing uncertainty.  Academic Article
• Locally advanced breast cancer in octogenarian women.  Academic Article
• Long-term hazard of recurrence in HER2+ breast cancer patients untreated with anti-HER2 therapy.  Academic Article
• Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.  Academic Article
• Long-term outcome of a pediatric-inspired regimen used for adults aged 18-50 years with newly diagnosed acute lymphoblastic leukemia.  Academic Article
• Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000).  Academic Article
• Long-term results of a pilot study for the treatment of advanced unresectable head and neck tumors by combination chemotherapy and split course radiotherapy.  Academic Article
• Long-term survival following extra-neural metastasis from a pineoblastoma.  Academic Article
• Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).  Academic Article
• Lung cancer chemotherapy agents increase procoagulant activity via protein disulfide isomerase-dependent tissue factor decryption.  Academic Article
• Lung cancer.  Academic Article
• Management of Ontario children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols.  Academic Article
• Management of advanced or recurrent cervical cancer: chemotherapy and beyond.  Academic Article
• Management of children with acute lymphoblastic leukemia by the Dana-Farber Cancer Institute protocols. An update of the Ontario experience.  Academic Article
• Management of unresected stage III non-small cell lung cancer: a systematic review.  Academic Article
• Megestrol acetate plus minidose diethylstilbestrol in the treatment of carcinoma of the prostate.  Academic Article
• Melena: a rare presentation of childhood Burkitt's lymphoma.  Academic Article
• Metastatic Merkel cell tumor to the prostate and bladder.  Academic Article
• Method to our madness or madness in our methods? Pitfalls in trial methodology.  Academic Article
• Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.  Academic Article
• Mineral homeostasis and bone mass in children treated for acute lymphoblastic leukemia.  Academic Article
• Modified adriamycin-vincristine-dexamethasone (m-VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study. The National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Modulation of the antitumor effect of methotrexate by low-dose leucovorin in squamous cell head and neck cancer: a randomized placebo-controlled clinical trial.  Academic Article
• More evidence that locoregional radiation therapy improves survival: what should we do?  Academic Article
• NCCN Task Force Report: Adjuvant Therapy for Breast Cancer.  Academic Article
• Natural history and chemotherapy effectiveness for advanced adenocarcinoma of the small bowel: a retrospective review of 113 cases.  Academic Article
• Neoadjuvant Gemcitabine Chemotherapy followed by Concurrent IMRT Simultaneous Boost Achieves High R0 Resection in Borderline Resectable Pancreatic Cancer Patients.  Academic Article
• Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial.  Academic Article
• Neoadjuvant or adjuvant therapy for resectable gastric cancer: a systematic review and practice guideline for North America.  Academic Article
• Neonatal hepatoblastoma: two cases posing a diagnostic dilemma, with a review of the literature.  Academic Article
• Neutropenia as a potential pharmacodynamic marker for docetaxel-based chemotherapy in men with metastatic castration-resistant prostate cancer.  Academic Article
• Nivolumab plus ipilimumab as first-line treatment for advanced non-small-cell lung cancer (CheckMate 012): results of an open-label, phase 1, multicohort study.  Academic Article
• Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents.  Academic Article
• Obstructive jaundice caused by neuroblastoma managed with temporary cholecystostomy tube.  Academic Article
• Offering a choice between two adjuvant chemotherapy regimens: a pilot study to develop a decision aid for women with breast cancer.  Conference Paper
• Oligodendroglioma.  Academic Article
• Opinions in pediatric and adolescent gynecology. Does oral contraceptive therapy do more harm than good in adolescents who are receiving chemotherapy?  Academic Article
• Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05).  Academic Article
• Osteopenia in children with acute lymphoblastic leukemia: a pilot study of amelioration with Pamidronate.  Academic Article
• Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy.  Academic Article
• Outcomes in patients with clinical stage III NSGCT who achieve complete clinical response to chemotherapy at extraretroperitoneal disease site.  Academic Article
• Ovarian ablation as adjuvant therapy for early-stage breast cancer.  Academic Article
• Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study.  Academic Article
• Ovarian suppression/ablation in premenopausal ER-positive breast cancer patients. Issues and recommendations.  Academic Article
• PANCREOX: A Randomized Phase III Study of Fluorouracil/Leucovorin With or Without Oxaliplatin for Second-Line Advanced Pancreatic Cancer in Patients Who Have Received Gemcitabine-Based Chemotherapy.  Academic Article
• PML/RAR alpha APL with undifferentiated morphology and stem cell immunophenotype.  Academic Article
• Paclitaxel and bevacizumab with or without capecitabine as first-line treatment for HER2-negative locally recurrent or metastatic breast cancer: a multicentre, open-label, randomised phase 2 trial.  Academic Article
• Palbociclib in hormone receptor positive advanced breast cancer: A cost-utility analysis.  Academic Article
• Paraspinal synovial sarcoma as an unusual postradiation complication in pediatric abdominal neuroblastoma.  Academic Article
• Patients' preferences for therapy in advanced epithelial ovarian cancer: development, testing, and application of a bedside decision instrument.  Academic Article
• Patterns of disease progression and outcomes in a randomized trial testing ABVD alone for patients with limited-stage Hodgkin lymphoma.  Academic Article
• Pharmacoeconomics of systemic therapies for lung cancer.  Academic Article
• Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel.  Academic Article
• Phase 2 Study of Erlotinib in Combination With Linsitinib (OSI-906) or Placebo in Chemotherapy-Naive Patients With Non-Small-Cell Lung Cancer and Activating Epidermal Growth Factor Receptor Mutations.  Academic Article
• Phase 2 trial of preoperative irinotecan plus cisplatin and conformal radiotherapy, followed by surgery for esophageal cancer.  Academic Article
• Phase I Dose-Escalation Study of Linsitinib (OSI-906) and Erlotinib in Patients with Advanced Solid Tumors.  Academic Article
• Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials group.  Academic Article
• Phase I studies of fluorouracil, doxorubicin and vinorelbine without (FAN) and with (SUPERFAN) folinic acid in patients with advanced breast cancer.  Academic Article
• Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98).  Academic Article
• Phase I study of combination topotecan and carboplatin in pediatric solid tumors.  Academic Article
• Phase I study of decitabine in combination with vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas.  Academic Article
• Phase I targeted combination trial of sorafenib and erlotinib in patients with advanced solid tumors.  Academic Article
• Phase I trial of UCN-01 in combination with topotecan in patients with advanced solid cancers: a Princess Margaret Hospital Phase II Consortium study.  Academic Article
• Phase I trial of gemcitabine, doxorubicin and cisplatin (GAP) in patients with advanced solid tumors.  Academic Article
• Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancer.  Academic Article
• Phase I/II study of pemetrexed with or without ABT-751 in advanced or metastatic non-small-cell lung cancer.  Academic Article
• Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: a Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group Study.  Conference Paper
• Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of response.  Academic Article
• Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphoma.  Academic Article
• Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.  Academic Article
• Phase II study of pemetrexed disodium, a multitargeted antifolate, and cisplatin as first-line therapy in patients with advanced nonsmall cell lung carcinoma: a study of the National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study.  Academic Article
• Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Phase II trial of OGX-011 in combination with docetaxel in metastatic breast cancer.  Academic Article
• Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response.  Academic Article
• Phase III comparative study of vinorelbine combined with doxorubicin versus doxorubicin alone in disseminated metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA8.  Academic Article
• Phase III study of N,N-diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine (BMS-217380-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA.19.  Academic Article
• Phosphoinositide 3-kinase inhibitors in advanced breast cancer: A systematic review and meta-analysis.  Academic Article
• Physical Activity in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood and Adolescence: A Cross-sectional Cohort Study.  Academic Article
• Pilot studies of superfractionated radiotherapy and combination chemotherapy in limited oat cell carcinoma of the bronchus.  Academic Article
• Platinum-based chemotherapy in triple-negative advanced breast cancer.  Academic Article
• Point/counterpoint: early-stage Hodgkin lymphoma and the role of radiation therapy.  Academic Article
• Postmenopausal breast cancer: is the short-term pain worth the long-term gain?  Academic Article
• Postrenal transplant malignancies in a living-related donor program.  Academic Article
• Posttreatment prognostic nomogram for patients with metastatic urothelial cancer completing first-line cisplatin-based chemotherapy.  Academic Article
• Predicting Anthracycline Benefit: TOP2A and CEP17-Not Only but Also.  Academic Article
• Prediction of response of patients with acute nonlymphocytic leukaemia to remission induction therapy: use of clinical measurements.  Academic Article
• Predictors of bony morbidity in children with acute lymphoblastic leukemia.  Academic Article
• Preoperative or postoperative therapy for stage II or III rectal cancer: an updated practice guideline.  Academic Article
• Primary gastric lymphoma with florid granulomatous reaction.  Academic Article
• Primary tracheal Ewing's sarcoma.  Academic Article
• Prognostic and predictive investigation of PAM50 intrinsic subtypes in the NCIC CTG MA.21 phase III chemotherapy trial.  Academic Article
• Prognostic associations of 25 hydroxy vitamin D in NCIC CTG MA.21, a phase III adjuvant randomized clinical trial of three chemotherapy regimens in high-risk breast cancer.  Academic Article
• Prognostic impact of the neutrophil-to-lymphocyte ratio in men with metastatic castration-resistant prostate cancer.  Academic Article
• Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.  Academic Article
• Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemotherapy trials.  Academic Article
• Prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor decrease febrile neutropenia after chemotherapy in children with cancer: a meta-analysis of randomized controlled trials.  Academic Article
• Prospective Evaluation of the 21-Gene Recurrence Score Assay for Breast Cancer Decision-Making in Ontario.  Academic Article
• Prospective Validation of a 21-Gene Expression Assay in Breast Cancer.  Academic Article
• Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.  Academic Article
• Protocol-based treatment for children with cancer in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology/Oncology (MISPHO)--part II.  Academic Article
• Pyomyositis Causing Temporary Quadriparesis During Induction Therapy for Acute Lymphoblastic Leukemia: Case Report and Review of the Literature.  Academic Article
• Radiation in early-stage Hodgkin lymphoma.  Academic Article
• Radiographic progression by Prostate Cancer Working Group (PCWG)-2 criteria as an intermediate endpoint for drug development in metastatic castration-resistant prostate cancer.  Academic Article
• Radiotherapy and adjuvant chemotherapy for childhood medulloblastoma. The Royal Marsden Hospital experience.  Academic Article
• Radiotherapy to control CNS lymphomatoid granulomatosis: a case report and review of the literature.  Academic Article
• Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.  Academic Article
• Randomized comparison of ABVD chemotherapy with a strategy that includes radiation therapy in patients with limited-stage Hodgkin's lymphoma: National Cancer Institute of Canada Clinical Trials Group and the Eastern Cooperative Oncology Group.  Academic Article
• Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.  Academic Article
• Randomized phase II comparison of standard CHOP with weekly CHOP in elderly patients with non-Hodgkin's lymphoma.  Academic Article
• Randomized phase II feasibility study of combining the matrix metalloproteinase inhibitor BMS-275291 with paclitaxel plus carboplatin in advanced non-small cell lung cancer.  Academic Article
• Randomized phase II study of modified FOLFOX-6 in combination with ramucirumab or icrucumab as second-line therapy in patients with metastatic colorectal cancer after disease progression on first-line irinotecan-based therapy.  Academic Article
• Randomized phase II trial of Custirsen (OGX-011) in combination with docetaxel or mitoxantrone as second-line therapy in patients with metastatic castrate-resistant prostate cancer progressing after first-line docetaxel: CUOG trial P-06c.  Academic Article
• Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.  Academic Article
• Randomized phase III study of matrix metalloproteinase inhibitor BMS-275291 in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer: National Cancer Institute of Canada-Clinical Trials Group Study BR.18.  Academic Article
• Randomized phase III trial comparing irinotecan/cisplatin with etoposide/cisplatin in patients with previously untreated extensive-stage disease small-cell lung cancer.  Conference Paper
• Randomized trial comparing cyclophosphamide, epirubicin, and fluorouracil with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer: update of National Cancer Institute of Canada Clinical Trials Group Trial MA5.  Academic Article
• Randomized trial of cyclophosphamide, methotrexate, and fluorouracil chemotherapy added to tamoxifen as adjuvant therapy in postmenopausal women with node-positive estrogen and/or progesterone receptor-positive breast cancer: a report of the National Cancer Institute of Canada Clinical Trials Group. Breast Cancer Site Group.  Academic Article
• Randomized trial of high-dose chemotherapy with autologous peripheral-blood stem-cell support compared with standard-dose chemotherapy in women with metastatic breast cancer: NCIC MA.16.  Academic Article
• Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.  Academic Article
• Randomized, double-blind trial of carboplatin and paclitaxel with either daily oral cediranib or placebo in advanced non-small-cell lung cancer: NCIC clinical trials group BR24 study.  Academic Article
• Randomized, placebo-controlled, phase III study of first-line oxaliplatin-based chemotherapy plus PTK787/ZK 222584, an oral vascular endothelial growth factor receptor inhibitor, in patients with metastatic colorectal adenocarcinoma.  Academic Article
• Reduction in serum clusterin is a potential therapeutic biomarker in patients with castration-resistant prostate cancer treated with custirsen.  Academic Article
• Relapse-free survival of statistically standardized continuous RT-PCR estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): NCIC CTG MA.14.  Academic Article
• Relation between platinum-DNA adducts and complete remission in adult acute nonlymphocytic leukemia.  Academic Article
• Relationship between the per cent of marrow cells in S phase and the outcome of remission-induction therapy for acute nonlymphocytic leukaemia.  Academic Article
• Responsiveness of intrinsic subtypes to adjuvant anthracycline substitution in the NCIC.CTG MA.5 randomized trial.  Academic Article
• Results of a multicenter randomized phase II trial of thalidomide and prednisone maintenance therapy for multiple myeloma after autologous stem cell transplant.  Academic Article
• Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group.  Academic Article
• Risk of premature menopause after treatment for Hodgkin's lymphoma.  Academic Article
• Safety and efficacy of everolimus with exemestane vs. exemestane alone in elderly patients with HER2-negative, hormone receptor-positive breast cancer in BOLERO-2.  Academic Article
• Safety of treatment of metastatic breast cancer with trastuzumab beyond disease progression.  Academic Article
• Salvage chemotherapy and autologous stem cell transplantation for transformed indolent lymphoma: a subset analysis of NCIC CTG LY12.  Academic Article
• Salvage surgery after induction chemotherapy with paclitaxel/cisplatin and primary radiotherapy for advanced laryngeal and hypopharyngeal carcinomas.  Academic Article
• Selection of adjuvant chemotherapy for treatment of node-positive breast cancer.  Academic Article
• Serotonin transporter antagonists target tumor-initiating cells in a transgenic mouse model of breast cancer.  Academic Article
• Side effects associated with the use of dexamethasone for prophylaxis of delayed emesis after moderately emetogenic chemotherapy.  Academic Article
• Single-agent Taxane Versus Taxane-containing Combination Chemotherapy as Salvage Therapy for Advanced Urothelial Carcinoma.  Academic Article
• Skeletal morbidity in childhood acute lymphoblastic leukemia.  Academic Article
• Sorafenib in combination with gemcitabine in recurrent epithelial ovarian cancer: a study of the Princess Margaret Hospital Phase II Consortium.  Academic Article
• Spindle epithelial tumor with thymus-like elements of the thyroid: a multi-institutional case series and review of the literature.  Academic Article
• Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.  Academic Article
• Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada.  Academic Article
• Superiority of granisetron to dexamethasone plus prochlorperazine in the prevention of chemotherapy-induced emesis.  Academic Article
• Supplementation with fish oil increases first-line chemotherapy efficacy in patients with advanced nonsmall cell lung cancer.  Academic Article
• Surgery as sole treatment for serous borderline tumors of the ovary with noninvasive implants.  Academic Article
• Survival and PSA response of patients in the TAX 327 study who crossed over to receive docetaxel after mitoxantrone or vice versa.  Academic Article
• Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexate-5-fluorouracil chemotherapy in head and neck cancer.  Academic Article
• Synergistic antitumor effects of regulatory T cell blockade combined with pemetrexed in murine malignant mesothelioma.  Academic Article
• Systemic Therapy for Previously Untreated Advanced BRAF-Mutated Melanoma: A Systematic Review and Network Meta-Analysis of Randomized Clinical Trials.  Academic Article
• Systemic adjuvant therapy for node-negative breast cancer: proven or premature?  Academic Article
• Tailored targeted therapy for all: a realistic and worthwhile objective against.  Academic Article
• Targeting the epidermal growth factor receptor in non-small-cell lung cancer: who, which, when, and how?  Academic Article
• Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179).  Academic Article
• Temsirolimus, interferon alfa, or both for advanced renal-cell carcinoma.  Academic Article
• The CDK inhibitor AT7519M in patients with relapsed or refractory chronic lymphocytic leukemia (CLL) and mantle cell lymphoma. A Phase II study of the Canadian Cancer Trials Group.  Academic Article
• The Canadian experience with intensive fluorouracil, epirubicin and cyclophosphamide in patients with early stage breast cancer.  Academic Article
• The Impact of Adding Taxanes to Gemcitabine and Platinum Chemotherapy for the First-Line Therapy of Advanced or Metastatic Urothelial Cancer: A Systematic Review and Meta-analysis.  Academic Article
• The development of thromboembolism may increase the risk of osteonecrosis in children with acute lymphoblastic leukemia.  Academic Article
• The effect of systemic adjuvant chemotherapy on local breast recurrence in node positive breast cancer patients treated by lumpectomy without radiation.  Academic Article
• The histone deacetylase inhibitor valproic acid alters sensitivity towards all trans retinoic acid in acute myeloblastic leukemia cells.  Academic Article
• The rapid uptake of concurrent chemotherapy for cervix cancer patients treated with curative radiation.  Conference Paper
• The role of dose intensity in determining outcome in intermediate-grade non-Hodgkin's lymphoma.  Academic Article
• The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review.  Academic Article
• The selective use of AMSA following high-dose cytarabine in patients with acute myeloid leukaemia in relapse: a Leukemia Intergroup study.  Academic Article
• The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.  Academic Article
• The treatment of patients with newly diagnosed poor prognosis acute myelogenous leukaemia: response to treatment and treatment failure.  Academic Article
• The use of VP-16 plus cisplatin during induction chemotherapy for small-cell lung cancer.  Academic Article
• The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.  Academic Article
• Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease.  Academic Article
• Thrombosis in children with acute lymphoblastic leukemia treated at a tertiary care center in Lebanon: revisiting the role of predictive models.  Academic Article
• Tirapazamine with cisplatin in patients with advanced non-small-cell lung cancer: a phase II study.  Academic Article
• Tolerance of radiotherapy and chemotherapy in elderly patients with bladder cancer.  Academic Article
• Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy.  Academic Article
• Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial.  Academic Article
• Toxic megacolon associated with anticancer chemotherapy.  Academic Article
• Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials.  Academic Article
• Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study.  Academic Article
• Treatment of advanced Hodgkin's disease with chemotherapy--comparison of MOPP/ABV hybrid regimen with alternating courses of MOPP and ABVD: a report from the National Cancer Institute of Canada clinical trials group.  Academic Article
• Treatment of early epithelial ovarian cancer with chemotherapy and abdominopelvic radiotherapy: results of a prospective treatment protocol.  Conference Paper
• Treatment of patients with acute nonlymphocytic leukemia in relapse: a Leukemia Intergroup study.  Academic Article
• Treatment strategies in elderly patients with aggressive histology lymphoma.  Academic Article
• Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma.  Academic Article
• UCN-01 in combination with topotecan in patients with advanced recurrent ovarian cancer: a study of the Princess Margaret Hospital Phase II consortium.  Academic Article
• Unresected stage III non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.  Academic Article
• Use of palliative end points to evaluate the effects of mitoxantrone and low-dose prednisone in patients with hormonally resistant prostate cancer.  Academic Article
• VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma.  Academic Article
• Vaginal Yolk Sac Tumor in an Infant: A Case Report and Literature Review of the Last 30 Years.  Academic Article
• Validated or not validated? That is the question.  Academic Article
• Validation of the Association of RECIST Changes With Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated on SWOG Study S0421.  Academic Article
• Weekly cyclophosphamide and alternate-day prednisone: an effective secondary therapy in multiple myeloma.  Academic Article
• Weekly intravenous methotrexate with folinic acid for nonmetastatic gestational trophoblastic neoplasia.  Academic Article
• Weight gain in breast cancer survivors: prevalence, pattern and health consequences.  Academic Article
• Women's perceptions of home-based exercise performed during adjuvant chemotherapy for breast cancer.  Academic Article
• [The significance of hormone receptor content in primary tumors for cytostatic therapy of advanced breast carcinoma].  Academic Article